“arch-venture-partners” Archives

in
Entry Author Date Location
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
Join Xconomy in December for What’s Hot in Bay Area Biotech 10/13/17 San Francisco
KSQ Bets on CRISPR-Juiced Drug Discovery With $76M & Ex-Genzyme CEO 10/02/17 Boston
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Aira Raises $12M to Expand Services for Blind and Visually Impaired 05/19/17 San Diego
Stalled or Rising Momentum? New York Wrestles With Its Biotech Future 05/10/17 New York
How Boragen Banked $10M to Develop New Boron-Based Fungicides 03/06/17 Raleigh Durham
Join Xconomy in June for ‘What’s Hot In Cancer Immunotherapy 2017’ 03/01/17 Seattle
Business Leaders Talk Trump’s Impact on Visas, Drug Pricing, Insurance 01/20/17 National
Under New Ownership, Alfalight Remains Laser-Focused 01/17/17 Wisconsin
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech 12/30/16 New York
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
ApoGen Biotechnologies Garners $7,000,000 Series A Financing 12/13/16 Seattle
ApoGen Biotech Lands $7M to Take On Drug Resistance in Cancer 12/12/16 Seattle
Nohla Therapeutics Garners $43,500,000 Series A Financing 12/01/16 Seattle
New York Institutions, VCs Team up to Build Drug Discovery “Bridge” 10/31/16 New York
UNITY Biotechnology Lands $116,000,000 Series B Funding 10/31/16 San Francisco
Unity Nabs $116M To Bring “Diseases of Aging” Drugs Into Human Trials 10/27/16 San Francisco
BlackThorn Therapeutics Garners $40,000,000 Series A Round 10/21/16 San Francisco
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
New Rockefeller Prez Takes Stock of “Wildly Underdeveloped” NY Bio Scene 09/27/16 New York
WA State’s Healthcare Transformation Checkup: How Are We Feeling Today? 08/09/16 Seattle
Just Biotherapeutics Secures $14,000,000 Series A Funding 07/26/16 Seattle
Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals 07/18/16 San Diego
Sienna Biopharmaceuticals Garners $12,000,000 Series A Financing 07/13/16 San Diego
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Alexandria Sets up Incubator, $25M Seed Fund For NY Bio Startups 06/08/16 New York
Page 1 of 16 next page »